Japan Patent for Cyclosporin Brain-Protection Granted to Maas BiolAB.ALBUQUERQUE, N.M. -- Maas BiolAB, LLC (Logical Link Control) See "LANs" under data link protocol.
LLC - Logical Link Control announced that the Japan Patent Office has granted patent number 3643380. The Maas Japan patent is for Cyclosporin Neuroprotection treating the gamut of neurological diseases. Cyclosporin has been shown to be a powerful and effective neuroprotectant in preclinical models of neurological diseases from traumatic brain injury Traumatic brain injury (TBI), traumatic injuries to the brain, also called intracranial injury, or simply head injury, occurs when a sudden trauma causes brain damage. TBI can result from a closed head injury or a penetrating head injury and is one of two subsets of acquired brain to amyotrophic lateral sclerosis amyotrophic lateral sclerosis (ALS) (ā'mīətrōf`ik, sklĭrō`sĭs) or motor neuron disease, (ALS Als (äls), Ger. Alsen, island, 121 sq mi (313 sq km), Sønderjylland co., S Denmark, in the Lille Bælt, separated from the mainland by the narrow Alensund. ). Japan, with a population of 127 million people, is the second largest pharmaceutical market in the world.
Maas BiolAB has been granted patents in 36 countries including North America (USA, Canada, Mexico), Europe (Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Ireland, Italy, Latvia, Lithuania, Luxembourg, Monaco, Netherlands, Portugal, Slovenia, Spain, Sweden, Switzerland, United Kingdom), Africa (Ghana, Kenya, Lesotho, Malawi, Sudan, Swaziland, Uganda, Zimbabwe), Antipodes Antipodes, islands, New Zealand
Antipodes (ăntĭp`ədēz), rocky uninhabited islands, 24 sq mi (62 sq km), South Pacific, c.550 mi (885 km) SE of New Zealand, to which they belong. (Australia, New Zealand), Russia, China, and now Japan.
The FDA FDA
Food and Drug Administration
n.pr See Food and Drug Administration.
n.pr the abbreviation for the Food and Drug Administration. has granted Orphan Drug designation to Maas BiolAB for cyclosporin as a treatment for ALS.
Cyclosporin is a unique drug that protects the mitochondria within neurons from the streams of attack found in degenerative brain diseases and injury. The mitochondria are energy generators within human cells. Cyclosporin protects these mitochondria, blocking neuron death and preserving normal brain function.
Maas BiolAB, LLC is a privately held neuropharmaceutical corporation based in Albuquerque, NM, USA. Maas BiolAB, LLC has licensed the world rights for cyclosporin neuroprotection in the ACUTE indications of traumatic brain injury, spinal cord injury Spinal Cord Injury Definition
Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control.
Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States. and stroke to its subsidiary NeuroPharma AB of Lund, Sweden (www.neuropharma.se). Maas BiolAB, LLC has licensed the world rights for cyclosporin neuroprotection in the CHRONIC neurodegeneration indications of amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease and Alzheimer's disease to its subsidiary Maas Biolab Inc, also of Albuquerque (www.maasbiolab.com).